{
    "organizations": [],
    "uuid": "a4cbd280cc47ab0be6412c7a4bb61f0a934c48b2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-starpharma-holdings-says-co-to-com/brief-starpharma-holdings-says-co-to-commence-dep-cabazitaxel-phase-1-2-trial-idUSFWN1PP1FQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Starpharma Holdings Says Co To Commence DEP Cabazitaxel Phase 1/2 Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Starpharma Holdings Ltd:\n* RECEIVED REGULATORY AND ETHICS APPROVAL TO COMMENCE ITS PHASE-1/2 CLINICAL TRIAL DOE DEP CABAZITAXEL‍​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-31T08:10:00.000+02:00",
    "crawled": "2018-01-31T16:52:43.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "starpharma",
        "holding",
        "ltd",
        "received",
        "regulatory",
        "ethic",
        "approval",
        "commence",
        "clinical",
        "trial",
        "doe",
        "dep",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}